Uncategorized

Trial By Error: Will MAGENTA’s Null Results Finally End Professor Crawley’s Long ‘Reign of Error’?

By David Tuller, DrPH For years, Professor Esther Crawley, the University of Bristol’s methodologically and ethically challenged ME/CFS investigator, has hoovered up millions of pounds from public and private funders to support her misbegotten research. She achieved this success as a grant magnet despite abundant and easily available evidence that she was violating core principles …

Trial By Error: Will MAGENTA’s Null Results Finally End Professor Crawley’s Long ‘Reign of Error’? Read More »

Trial By Error: An Interview with Neuroscientist Michael VanElzakker about the Just-Published and Long-Awaited NIH Study

By David Tuller, DrPH So, okay…The big enchilada from the US National Institutes of Health’s seven-year, $8-million, under-recruited and over-hyped study—”Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome”–was published last week in Nature Communications. It would be fair to describe the ensuing public debate over this massive text-and-data dump as spirited. (NIH press release here; …

Trial By Error: An Interview with Neuroscientist Michael VanElzakker about the Just-Published and Long-Awaited NIH Study Read More »

Trial By Error: New Long Covid Exercise-and-Therapy Study Claims Success Despite Clinically Insignificant Findings

By David Tuller, DrPH A new study of an online group physical and psychological rehabilitation program for Long Covid confirms once again that people given an intervention purporting to help them are more likely to tell investigators that they feel better than those given nothing of the kind. People, this is not a surprising result! …

Trial By Error: New Long Covid Exercise-and-Therapy Study Claims Success Despite Clinically Insignificant Findings Read More »

Trial By Error: Leading FND Site Confirms Criticisms on Prevalence Outlined in Our Letter to Neurology Journal

By David Tuller, DrPH In two recent posts, here and here, I wrote about our letter on inflated prevalence claims for functional neurological disorder (FND) and about the response from the authors of the study we criticized. The 2021 article in NeuroImage: Clinical, “Neuroimaging in functional neurological disorder: state of the field and research agenda,” asserted …

Trial By Error: Leading FND Site Confirms Criticisms on Prevalence Outlined in Our Letter to Neurology Journal Read More »

Trial By Error: Unconvincing Response to Letter on FND Prevalence Inflation

By David Tuller, DrPH As I wrote in a post the other day, the journal NeuroImage: Clinical has just published a letter from a group I organized about the misrepresentation of findings regarding the prevalence of functional neurological disorder (FND). They have also published a response from the authors of the article we criticized. The …

Trial By Error: Unconvincing Response to Letter on FND Prevalence Inflation Read More »

Trial By Error: Finally, Our Letter on Inflated Claims of FND Prevalence Is Published

By David Tuller, DrPH For more than a year, I have been criticizing experts in the field of functional neurological disorder for misrepresenting the findings of a seminal study, in effect tripling the reported prevalence rate of the condition. These untrue claims about the Scottish Neurological Symptoms Study (SNSS)—specifically, that the prevalence of FND among …

Trial By Error: Finally, Our Letter on Inflated Claims of FND Prevalence Is Published Read More »

Scroll to Top